Sugi Predict

Sugi Predict / Compounds / SCHEMBL600330

SCHEMBL600330

SCHEMBL600330

O=C(O)c1cccc2c1-c1ccccc1C2=O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.85
▸ L3MBTL1 Q9Y468 1/20 0.85
▸ MAPT P10636 4/20 0.72
▸ LMNA P02545 2/20 0.72
▸ KEAP1 Q14145 4/20 0.70
▸ NFE2L2 Q16236 1/20 0.70
▸ MEN1 O00255 5/20 0.59
▸ KMT2A Q03164 5/20 0.59
▸ POLB P06746 3/20 0.59
▸ MAPK1 P28482 2/20 0.59
▸ THRB P10828 1/20 0.59
▸ RECQL P46063 1/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.54
▸ MMP14 P50281 1/20 0.54
▸ TP53 P04637 1/20 0.54
▸ HNF4A P41235 1/20 0.53
▸ TTR P02766 1/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ GAA P10253 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30808237 1.00 ALDH1A1 (0.85) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL31276140 1.00 ALDH1A1 (0.85) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL461660 0.92 ALDH1A1 (1.00) ALDH1A1L3MBTL1MAPTLMNAKEAP1
Anthraquinone SCHEMBL8941397 0.92 ALDH1A1 (1.00) ALDH1A1L3MBTL1MAPTLMNAKEAP1
Hydrochloric Acid SCHEMBL8675457 0.90 ALDH1A1 (0.96) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL69960 0.88 ALDH1A1 (0.85) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL3616574 0.85 ALDH1A1 (0.74) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL31278212 0.85 ALDH1A1 (0.74) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL69132 0.85 ALDH1A1 (0.88) ALDH1A1L3MBTL1MAPTLMNAKEAP1
SCHEMBL581124 0.84 ALDH1A1 (1.00) ALDH1A1L3MBTL1MAPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 568 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12628491-B2 Organic-inorganic adhesion layer and its use in perovskite solar cells and modules Tandem PV (US) 2026-05-12 — — US claimed
CN-119661577-A Preparation method of maxacalcitol intermediate B 杭州福斯特药业有限公司 2025-03-21 — — CN claimed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 — — CN claimed
WO-2024081751-A1 ORGANIC-INORGANIC ADHESION LAYER AND ITS USE IN PEROVSKITE SOLAR CELLS AND MODULES Tandem PV (US) 2024-04-18 — — WO claimed
US-20240121970-A1 ORGANIC-INORGANIC ADHESION LAYER AND ITS USE IN PEROVSKITE SOLAR CELLS AND MODULES Tandem PV 2024-04-11 — — US claimed
CN-108794760-B Cd (II) coordination polymer containing 9-fluorenone-4-carboxylic acid and preparation method thereof 宁夏大学 2020-09-04 — — CN claimed
CN-108794760-A A kind of Cd (II) coordination polymer and preparation method thereof containing 9-Fluorenone -4- carboxylic acids 宁夏大学 2018-11-13 — — CN claimed
CN-103159693-A Chiral aryl-substituted phenyl-1,3-oxazoline compound and synthesis method thereof UNIV SHANGHAI 2013-06-19 — — CN claimed
US-7732625-B2 Colorant compounds XEROX CORPORATION (US) 2010-06-08 — — US claimed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 — — US claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 — — US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 — — US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 — — US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 — — US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 — — US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 — — US claimed
US-4604295-A VISIBLE AND UV PHOTOINITIATORS FOR CURING ACRYLIC MONOMERS AND PREPOLYMERS LOCTITE CORPORATION (US) 1986-08-05 — — US claimed
EP-0147226-A2 Visible light absorbing peroxy esters LOCTITE CORPORATION (US) 1985-07-03 — — EP claimed
EP-4747233-A2 COMPOUNDS, COMPOSITIONS CONTAINING COMPOUNDS, AND METHODS OF MANUFACTURING RESIST MEMBRANES Merck Patent GmbH (DE) 2026-05-27 — — EP disclosed
US-4013623-A FREE RADICAL COPOLYMERIZATION, ELECTROGRAPHY XEROX CORPORATION (US) 1977-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 ALDH1A1 1569/4885L3MBTL1 598/4885MAPT 4074/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 ALDH1A1 1723/4885L3MBTL1 4695/4885MAPT 539/4885
US-12628491-B2 Organic-inorganic adhesion layer and its use in perovskite solar cells and modules EPCAM, CDH1, L1CAM ALDH1A1 1093/4885L3MBTL1 2162/4885MAPT 891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.